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 ABSTRACT 
 In the current study, the relative contribution of cell-
surface components (CSC) and cell-free supernatants 
(CFS) in the immuno-modulatory properties of 17 
strains of probiotic and lactic acid bacteria (LAB) was 
assessed. The production of pro- and antiinflammatory 
cytokines including IL-2, IL-4, IL-10, IL-12 p70, IFN-γ, 
tumor necrosis factor-α (TNF-α), and transforming 
growth factor-β was measured at different time points 
after stimulation of buffy coat derived-peripheral blood 
mononuclear cells (PBMC) from healthy donors with 
CSC and CFS of probiotic and LAB. Results showed 
that CSC of probiotic and LAB strains induced produc-
tion of T helper 1 and 2 type cytokines. Transforming 
growth factor-β was stimulated at highest concentra-
tions, followed by IL-10 and TNF-α. The CFS of all 
tested bacterial strains induced PBMC for significantly 
high levels of IL-10 secretion compared with unstimu-
lated cells, but the values were less than lipopolysaccha-
ride-stimulated cells. Cytokines due to CFS stimulation 
showed declined concentration for IL-2, TNF-α, and 
IL-4, and complete disappearance of IL-12, IFN-γ, and 
transforming growth factor-β in the cultured medium 
at 96 h of incubation. Results of cytokine data demon-
strate proinflammatory TNF-α immune responses are 
mainly directed through cell-surface structures of probi-
otic and LAB, but antiinflammatory immune responses 
are mediated both by metabolites and cell-surfaces of 
these bacteria. The induction of CD4+CD25+ regula-
tory T cells after stimulation of PBMC with CSC and 
CFS of probiotic and LAB showed regulatory T cell 
activity appeared to be influenced both by the CSC 
and metabolites, but was principally triggered by cell 
surfaces of probiotic and LAB strains. 
 Key words:   probiotic bacteria ,  cell-surface compo-
nent ,  cell-free culture supernatant ,  regulatory T-cell 
 INTRODUCTION 
 Probiotic foods are growing in popularity as foods 
containing live microorganisms that actively improve 
health by maintaining the balance of gut microflora and 
aiding in the treatment or prevention of some diseases. 
Many strains of lactic acid bacteria (LAB) are believed 
to have probiotic properties and offer various health 
benefits. Lactobacillus and Bifidobacterium strains used 
as probiotics have been well recognized for their role 
in preventing and treating acute gastrointestinal infec-
tions, diarrhea, allergy, atopic diseases, and inflamma-
tory bowel diseases (Van Niel et al., 2002; Clancy, 2003; 
Isolauri, 2004; Wickens et al., 2008; Ryan et al., 2009). 
The beneficial health effects of these strains are based 
primarily on their ability to regulate differentially the 
production of anti- and proinflammatory cytokines and 
the T helper (Th) 1 and Th2 balance. The immune 
responses classified as Th1 produce proinflammatory 
cytokines and are involved in cellular immunity against 
intracellular infections. The Th2-type responses pro-
duce variety of antiinflammatory cytokines and pro-
mote humoral immunity against extracellular patho-
gens. Live probiotic bacteria are capable of inducing 
enhanced mucin expression, phagocytosis, and different 
profiles of cytokines (Mattar et al., 2002; Shida et al., 
2006; Caballero-Franco et al., 2007; Suzuki et al., 2008; 
Kaji et al., 2010; Donkor et al., 2012). Induction of 
cytokines by probiotic and LAB indicates that these 
bacteria can stimulate immune responses and the ef-
fects can be exerted directly or indirectly. Although, 
mechanisms of these immunological responses are still 
not clear, it can be comprehended that different bac-
terial cell components and metabolites may account 
for the differences in immunological responses. These 
immunological effects in terms of cytokine production 
have been observed in in vitro and murine models by 
probiotic cell components, including peptidoglycan, cell 
wall, LPS, and DNA (Erickson and Hubbard, 2000; 
Lammers et al., 2003; Hessle et al., 2005; Matsumoto et 
al., 2005, 2009; Medina et al., 2007). Many components 
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of bacterial cell wall, such as LPS, peptidoglycans, and 
lipoteichoic acids, have shown to be involved in indirect 
stimulation of immune cells for cytokine production. 
Several conserved components of the bacterial cell wall 
have been shown to bind to receptors on the cell surface 
of monocytes and macrophages and induce the produc-
tion of proinflammatory cytokines (Underhill, 2003). It 
is stipulated that the cell wall components may activate 
macrophages, endothelial cells, smooth muscle cells, 
and neutrophils and, in turn, release some mediators. 
Mediators, such as tumor necrosis factor (TNF)-α, 
IL-1, IL-6, IL-8, IL-12, elastases and cathepsin, prosta-
glandins, as well as reactive oxygen and nitrogen spe-
cies, may be produced (Erickson and Hubbard, 2000; 
Hessle et al., 2005). Little is known about the precise 
mechanisms by which lactobacilli exert beneficial ef-
fects, but it is believed that it works through activation 
of innate immune system that recognizes conserved 
microbial structures by use of pattern recognition re-
ceptors, such as toll-like receptors, whose ligands may 
be gram-positive or -negative cell wall structures (Dogi 
et al., 2010). These structures have shown to induce 
immune response in several in vivo and in vitro experi-
mental models (Wang et al., 2003).
The antiinflammatory cytokines transforming growth 
factor (TGF)-β and IL-10 have also been implicated in 
regulatory T cell (Treg) function. The Treg are devel-
opmentally classified into natural, induced, or adaptive 
populations. The normal immune system endogenously 
produces normal cellular constituents of CD4+ T cell 
population that play a central role in immune protec-
tion. Most natural CD4+ Treg constitutively express 
CD25 molecule (IL-2 receptor α chain; Sakaguchi, 2005; 
Lavasani et al., 2010). The CD4+CD25+ Treg constitute 
a specialized subpopulation of T cells that suppress a 
range of effector cell types and thereby contribute to 
the maintenance of immune homeostasis (Sakaguchi et 
al., 1995). In vitro, CD4+CD25+ Treg have been shown 
to suppress the activation and expansion of naïve cells, 
which require direct contact of regulatory cells with 
target cells and secretion of the immuno-regulatory cy-
tokines IL-10 and TGF-β (von Boehmer, 2005; Fantini 
et al., 2007; Bollyky et al., 2009; Lavasani et al., 2010). 
The CD4+CD25+ Treg have been shown to suppress the 
development of autoimmune disease after cotransfer of 
CD4+CD25+ Treg in immuno-deficient recipients. The 
implication of CD4+CD25+ T cells in the inhibition of 
development of autoimmune diseases could appear to 
be both a cytokine-dependent and -independent pro-
cess (Asseman et al., 1999; Seddon and Mason, 1999; 
McHugh et al., 2001, 2002).
Our previous study and earlier research conducted in 
our laboratory established that probiotic strains differ 
in their ability to induce the production of proinflam-
matory cytokines, including IFN-γ, IL-12, TNF-α, and 
IL-2, and antiinflammatory cytokines, such as IL-10, 
IL-4 and TGF-β. Moreover, strain differences exist in 
inducing Treg population revealed by the induction 
of CD25 and FoxP3 expression in stimulated periph-
eral blood mononuclear cells (PBMC; Donkor et al., 
2012). The strain differences and variations in immune 
responses called for further detailed studies by focusing 
on cell free supernatants of probiotic bacteria before 
future in vivo experiments. The current study, there-
fore, investigated the cytokine profile and induction 
of CD4+CD25+ regulatory T cells after stimulation 
of PBMC with structural cell components and me-
tabolites of 17 strains of LAB and probiotic organisms. 
This will help determine the relative contribution and 
importance of structural components or extracellular-
secreted molecules of LAB and probiotic strains to 
overall immuno-modulatory activity of these strains. 
Moreover, it will also assist us in understanding the 
involvement of these cell fractions in the differentiation 
of Th cell subsets and induction of regulatory T cell 
population.
MATERIALS AND METHODS
Bacterial Strains and Enumeration of Bacterial Cells
Pure cultures of Lactobacillus bulgaricus ssp. del-
brueckii 11842, Streptococcus thermophilus M5, Lacto-
coccus lactis R704, Bifidobacterium lactis BB12 were 
provided by Chr. Hansen (Chr. Hansen Pty. Ltd., 
Bayswater, Australia) and Lactobacillus paracasei 292, 
Lactobacillus salivarius 5248, Lactobacillus reuteri, Lac-
tobacillus rhamnosus G5434, Lactobacillus acidophilus 
2401, Lb. acidophilus 388, Lactobacillus plantarum 276, 
Lb. rhamnosus 5434, Lc. lactis, S. thermophilus 1342, 
Lactobacillus casei 290, Bifidobacterium breve BB99, 
and Bifidobacterium longum 1941 were obtained from 
Victoria University Culture Collection (Werribee, Vic-
toria, Australia). The parent stock cultures were kept 
at −80°C in PBS containing 40% glycerol, whereas ly-
ophilized cultures were retained at −20°C in a freezer. 
Prior to the experiment, the cultures were activated 
in de Man, Rogosa, and Sharpe (MRS) broth (Oxoid, 
Melbourne, Australia) at 37°C for 18 h and samples 
were removed for Gram staining to check for purity and 
bacterial morphology. Bacteria were further grown on 
MRS agar (1.5% wt/vol agar) as a reference medium to 
observe the colonial characteristics.
The bacterial cell concentration was standardized by 
enumeration as colony-forming units per milliliter using 
the pour-plate technique. Briefly, bacteriological pep-
tone solution was used as diluent for the enumeration 
experiment and it was prepared by dissolving 0.15% 
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(wt/vol) bacteriological peptone (Oxoid) in milli-Q 
water. The pH of diluent was adjusted to 7.0 ± 0.2, 
dispensed in McCartney bottles (Labtek Laboratory 
Glassware Agencies, Brendale, QLD, Australia) in 9-mL 
aliquots, followed by autoclaving at 121°C for 15 min. 
For enumeration of bacterial cell number, 1 mL of each 
freshly prepared culture was 10-fold serially diluted and 
plated onto MRS agar (for bifidobacteria, supplemented 
with 0.05% l-Cys HCl). For bifidobacteria and lacto-
bacilli cultures, incubations were performed at 37°C for 
72 h anaerobically using anerobic gas generating kits 
(Oxoid) in anerobic jars; conversely, Lactococcus and 
Streptococcus strains were incubated at 37°C for 24 h 
aerobically.
Extraction of Cell-Surface Components
The cultures were activated successively 3 times 
in MRS broth (Oxoid), at 37°C for 18 h with a 1% 
inoculum transfer rate. All media were sterilized by 
autoclaving at 121°C for 15 min. For bifidobacteria, 
media were supplemented with membrane-filtered 
0.05% l-Cys HCl (Sigma-Aldrich, St. Louis, MO) to 
provide an anaerobic condition and to facilitate their 
growth. Cells were harvested by centrifugation (6,000 
× g for 15 min at 4°C; Beckman J2/HS centrifuge, 
JA-14 rotor, Palo Alto, CA) during the stationary 
growth phase, washed 2 times in PBS (130 mM so-
dium chloride, 10 mM sodium phosphate, pH 7.4), 
and resuspended in PBS containing 40% glycerol. The 
cell suspensions were adjusted to 1 × 106 cfu/mL and 
were subjected to 5 sonication cycles at 100 W output 
for 15 min each with 2-min intervals on ice, using a 
probe sonicator (Braun Biotech Inc., Allentown, PA). 
Cell debris was separated by centrifugation (10,000 × 
g for 10 min at 4°C; Beckman) and the supernatants 
were collected and standardized for protein concentra-
tion. The protein content of surface protein fractions 
was determined by the Bradford method using total 
protein kit (Sigma-Aldrich) and BSA (Sigma-Aldrich) 
as a standard, according to the manufacturer’s pro-
cedure. The samples of cell-surface components of all 
17 bacteria were standardized to 4 mg/mL of protein 
concentrations, aliquoted, and stored at −80°C until 
used. The absence of viability losses was confirmed by 
plate counting as described above.
Preparation of Cell-Free Culture Supernatants
To obtain cell-free culture supernatants, the spent 
MRS media (from where the cells were harvested), were 
filter-sterilized (0.45-μm pore size filter, Millipore, Bil-
lerica, MA) to eliminate the possible presence of viable 
cells. The supernatants were adjusted to pH 7.2 with 1 
M NaOH; MRS media without any inoculation was used 
as a control. Aliquots of cell-free culture supernatants 
samples were kept at −80°C until use. Viability test 
was performed after storage to exclude the chances of 
any contamination or the presence of any viable cells. A 
fresh aliquot of each sample was thawed for every new 
experiment to avoid variability in the samples between 
experiments.
Isolation of Human PBMC
Human PBMC were isolated from buffy coats (Aus-
tralian Red Cross Blood Services, Melbourne, Aus-
tralia). The proposed research project was accepted 
and deemed to meet the requirements of the National 
Health and Medical Research Council “National 
Statement on Ethical Conduct in Human Research” 
(National Health and Medical Research Council, 
2007) by the Chair of the Faculty of Health, Engineer-
ing, and Science, Victoria University Human Research 
Ethics Committee. Contract agreement was made 
with Australian Red Cross Blood Services Melbourne 
Australia, for the supply of buffy coat. The PBMC 
were isolated from individual buffy coat (60 mL) by 
centrifugation over a Ficoll-Paque Plus (GE Health-
care Pty Ltd., Silverwater, NSW, Australia) gradient. 
Briefly, buffy coats were diluted with an equal volume 
of 1× PBS that was freshly prepared from 10× PBS, 
pH 7.4 (Invitrogen Pty Ltd., Mount Waverly, Victoria, 
Australia), and layered on Ficoll-Paque Plus. Cells at 
the interphase were collected following centrifugation 
(400 × g for 30 min at 18°C, no brake; Sorvall RT7 
centrifuge, DuPont, Newtown, CT). The separated 
layers of PBMC were washed once in RPMI-1640 (In-
vitrogen) following centrifugation (400 × g at 18°C for 
10 min, no brake; Sorvall). The pellet was resuspended 
in 2 mL of ammonium-chloride-potassium (ACK) lys-
ing buffer (Invitrogen) and incubated for 2 min at 
room temperature. The volume was then adjusted 
to 30 mL using sterile PBS and centrifuged (250 × 
g for 10 min at 4°C, no brake; Sorvall). Following 2 
subsequent washes with RPMI-1640, the volume was 
adjusted to 3 × 106 cells/mL in RPMI-1640, supple-
mented with 10% FBS, qualified, and heat inactivated 
(Invitrogen) with 100 mg/mL of streptomycin (Sigma-
Aldrich) and 100 U/mL of penicillin (Sigma-Aldrich). 
The leftover cells were frozen at −80°C in a Nalgene 
Mr. Frosty Freezing Container (Thermo Fisher Scien-
tific Pty Ltd., Scoresby, Victoria, Australia), followed 
by transferring in liquid nitrogen. For freezing, the 
cells were resuspended in freeze mix (90% FBS + 10% 
dimethyl sulfoxide; Sigma-Aldrich) at 2.5 × 107 cells/
mL in aliquots of 1.5 mL per cryotube (Corning Inc., 
Clayton, Victoria, Australia).
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Stimulation of PBMC
For the stimulation steps, PBMC were incubated 
in 24-well flat-bottomed polystyrene microtiter plates 
(Sigma-Aldrich) with a final concentration of 1 × 106 
cells/mL in the presence or absence of different stimu-
lants at 37°C in 5% CO2 for different time slots. Final 
concentrations of 50 μL/mL of bacterial cell-free cul-
ture supernatant and 100 μg/mL of crude cell-surface 
component samples were used as stimulants. Purified 
LPS from Escherichia coli O111:B4 (Sigma-Aldrich) 
and concanavalin A from Canavalia A (Sigma-Aldrich) 
were used to stimulate PBMC at a concentration of 1 
and 5 μg/mL, respectively, as positive controls. Non-
stimulated PBMC were also evaluated as controls of 
basal cytokine production. Supernatants of stimulated 
and nonstimulated PBMC were collected at 24, 48, 72, 
and 96 h by centrifugation, fractionated in aliquots, 
and stored at −20°C until cytokines were analyzed.
Cytokine Assays
Cytokine concentrations of supernatants were mea-
sured by ELISA using BD OptEIA ELISA Sets (BD 
Bioscience, San Diego, CA), including IL-2, IL-4, IL-10, 
IL-12 (p70), IFN-γ, TNF-α, and TGF-β. The detection 
procedures were performed according to the manufac-
turer’s instructions. Data are expressed as the mean 
cytokine response minus background (pg/mL) of each 
treatment from triplicate wells, plus or minus the stan-
dard error of the mean.
Cell Staining and Flow Cytometry Analysis
For staining purposes, PBMC (106 cells) were co-
cultured with samples of 50 μL/mL of cell-free culture 
supernatants, 100 μg/mL of crude cell-surface com-
ponents, 1 mg/mL of LPS (Sigma-Aldrich) or media 
alone, in a 24-well plate at 37°C in 5% CO2 for 96 
h. After incubation, cells were washed twice using 
fluorescence-activated cell sorter (FACS) buffer (PBS 
+ 2% FACS) and centrifuged at 500 × g for 10 min. 
According to the manufacturer’s instructions, PBMC 
were resuspended at 106 cells/mL, stained with fluo-
rescent dye-conjugated antibodies, using fluorescein 
isothiocynate-labeled anti-human CD4, allophycocy-
anin-labeled anti-human CD25 (BD Bioscience), and 
peridinin chlorophyll protein-labeled antihuman CD3 
(Biolegend, San Diego, CA). Samples were analyzed 
using a BD FACS Calibur, data were acquired using 
Cell Quest program (BD Biosciences), and analysis of 
acquired data was performed using Flowlogic software 
(Inivai, Mentone, Victoria, Australia) for percent posi-
tive cells and expression levels of gated cells. Expres-
sion of CD25 on T lymphocyte population was evalu-
ated by gating on CD3+CD4+ cells and graphed for 
CD25 expression.
Statistical Analyses
Regression analysis was used as a goodness-of-fit 
measure of linear models. Significant differences be-
tween treatments were tested by ANOVA followed by a 
comparison between treatments performed by Fisher’s 
least significant difference method and multiple range 
test with a level of significance of P < 0.05. Data are 
expressed as mean and standard deviation of triplicate 
measures determined in 4 independent experiments.
RESULTS
Cytokine Production by PBMC upon Stimulation  
with Cell-Surface Components of Probiotic  
and LAB Strains
The immuno-modulatory characteristics of cell-
surface components of different strains of LAB and 
probiotic bacteria, in terms of cytokine production at 
different time points, are shown in Figures 1, 2, and 
3a to g. Results show that cell-surface components of 
probiotic and LAB strains produced Th1- and Th2-
type cytokine responses, where TGF-β was produced 
in higher concentrations followed by IL-10 and TNF-α. 
Of all proinflammatory cytokines determined, TNF-α 
was abundantly produced, followed by IL-12, IFN-γ, 
and IL-2. Among antiinflammatory cytokines, TGF-β 
had the highest concentration, followed by IL-10 and 
IL-4. Cell-surface protein fractions of all 17 bacteria 
induced significantly high levels (P < 0.05) of IL-2 
at 96 h and TNF-α at 48 and 96 h compared with 
unstimulated cells. The highest yield of TNF-α was 
found at 48 h in the range of 414 to 1,164 pg/mL. In 
addition, the production of TGF-β and IL-10 was also 
induced significantly more (P < 0.01) by all treated 
PBMC than untreated cells. Cell-surface fractions of 
S. thermophilus 1342, Lb. acidophilus 2401, Lb. rham-
nosus G5434, Lb. plantarum 276, B. breve BB99, Lb. 
rhamnosus 5434, and Lb. salivarius 5248 significantly 
(P < 0.05) increased levels of IL-12 at 72 h compared 
with unstimulated cells. Only cell-surface protein frac-
tions of Lb. delbrueckii ssp. bulgaricus 11842 induced 
IFN-γ secretion significantly (P < 0.05) greater than 
LPS-induced or nonstimulated cells. Interestingly, the 
production of all the tested cytokines was detected at 
24 h of stimulation and reached maximum concentra-
tions at 48 or 72 h of incubation as opposed to IL-2 and 
IL-10, for which maximum production was observed at 
96 h of stimulation.
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Figure 1. In vitro production of proinflammatory cytokines IL-2, IL-12, IFN-γ, and tumor necrosis factor α (TNF-α) by cell-surface compo-
nents and cell-free culture supernatants (see Figures 3 and 4 for details). Box plots showing the distribution of each proinflammatory cytokine 
secreted by peripheral blood mononuclear cells stimulated with cell-surface components and cell-free culture supernatants of 17 lactic acid 
bacterial strains. The middle of the box shows the median; the upper portion shows the third quartile of the population comprising 25% more 
population than the median; the lower portion shows first quartile up to 25% of population lower than the median; whiskers above and below 
the bars show maximum and minimum, respectively, of the distribution; and asterisks (*) show outliers.
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Figure 2. In vitro production of antiinflammatory cytokines IL-4, IL-10, and transforming growth factor β (TGF-β) by cell-surface compo-
nents and cell-free culture supernatants (see Figures 3 and 4 for details). Box plots showing the distribution of each proinflammatory cytokine 
secreted by peripheral blood mononuclear cells stimulated with cell-surface components and cell-free culture supernatants of 17 lactic acid 
bacterial strains. The middle of the box shows the median; the upper portion shows the third quartile of the population comprising 25% more 
population than median; the lower portion shows the first quartile up to 25% of population lower than median; whiskers above and below the 
bars show the maximum and minimum, respectively, of the distribution; and asterisks (*) show outliers.
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Figure 3. In vitro production of IL-2 (a), IL-4 (b), IL-10 (c), IL-12 (d), IFN-γ (e), tumor necrosis factor α (TNF-α; f), and transform-
ing growth factor β (TGF-β; g). Supernatants of 48-, 72-, and 96-h cocultures of pooled buffy coat-derived peripheral blood mononuclear 
cells (PBMC) treated with cell-surface components of lactic acid bacterial strains [Lactobacillus casei 290 (LC290), Bifidobacterium breve 
BB99 (BB99), Bifidobacterium animalis ssp. lactis BB12 (BB12), Bifidobacterium longum 1941 (BL1941), Lactococcus lactis R704 (LCR704), 
Lactobacillus plantarum 276 (LP276), Lactobacillus rhamnosus 5434 (LR5434), Streptococcus thermophilus M5 (STM5), Lactobacillus paracasei 
292 (LP292), Lactobacillus salivarius 5248 (LS5248), Lactobacillus reuteri, Lc. lactis, Lb. rhamnosus G5435 (LG5435), Lactobacillus acidophilus 
2401 (LA2401), Lb. acidophilus 388 (LA388), Lactobacillus delbrueckii ssp. bulgaricus 11842 (LB11842), and S. thermophilus 1342 (ST1342)] were 
collected. The PBMC in Roswell Park Memorial Institute (RPMI) medium alone (nonstimulated PBMC) were evaluated as controls for basal 
cytokine production. Purified LPS (1 μg/mL) from Escherichia coli O111:B4 and concanavalin A (5 μg/mL; ConA) from Canavalia A were used 
as positive controls. The concentration of cytokines was subsequently determined using ELISA kits. Results are expressed as the mean cytokine 
response (pg/mL) ± SEM as error bars of each treatment from triplicate wells run as 4 independent experiments.
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Figure 3 (Continued). In vitro production of IL-2 (a), IL-4 (b), IL-10 (c), IL-12 (d), IFN-γ (e), tumor necrosis factor α (TNF-α; f), and 
transforming growth factor β (TGF-β; g). Supernatants of 48-, 72-, and 96-h cocultures of pooled buffy coat-derived peripheral blood mono-
nuclear cells (PBMC) treated with cell-surface components of lactic acid bacterial strains [Lactobacillus casei 290 (LC290), Bifidobacterium breve 
BB99 (BB99), Bifidobacterium animalis ssp. lactis BB12 (BB12), Bifidobacterium longum 1941 (BL1941), Lactococcus lactis R704 (LCR704), 
Lactobacillus plantarum 276 (LP276), Lactobacillus rhamnosus 5434 (LR5434), Streptococcus thermophilus M5 (STM5), Lactobacillus paracasei 
292 (LP292), Lactobacillus salivarius 5248 (LS5248), Lactobacillus reuteri, Lc. lactis, Lb. rhamnosus G5435 (LG5435), Lactobacillus acidophilus 
2401 (LA2401), Lb. acidophilus 388 (LA388), Lactobacillus delbrueckii ssp. bulgaricus 11842 (LB11842), and S. thermophilus 1342 (ST1342)] were 
collected. The PBMC in Roswell Park Memorial Institute (RPMI) medium alone (nonstimulated PBMC) were evaluated as controls for basal 
cytokine production. Purified LPS (1 μg/mL) from Escherichia coli O111:B4 and concanavalin A (5 μg/mL; ConA) from Canavalia A were used 
as positive controls. The concentration of cytokines was subsequently determined using ELISA kits. Results are expressed as the mean cytokine 
response (pg/mL) ± SEM as error bars of each treatment from triplicate wells run as 4 independent experiments.
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Figure 4. In vitro production of IL-2 (a), IL-4 (b), IL-10 (c), IL-12 (d), IFN-γ (e), tumor necrosis factor α (TNF-α; f), and transform-
ing growth factor β (TGF-β; g). Supernatants of 24-, 48-, 72-, and 96-h cocultures of pooled buffy coat-derived peripheral blood mononuclear 
cells (PBMC) treated with cell-free supernatants of 17 strains of lactic acid bacteria [Lactobacillus casei 290 (LC290), Bifidobacterium breve 
BB99 (BB99), Bifidobacterium animalis ssp. lactis BB12 (BB12), Bifidobacterium longum 1941 (BL1941), Lactococcus lactis R704 (LCR704), 
Lactobacillus plantarum 276 (LP276), Lactobacillus rhamnosus 5434 (LR5434), Streptococcus thermophilus M5 (STM5), Lactobacillus paracasei 
292 (LP292), Lactobacillus salivarius 5248 (LS5248), Lactobacillus reuteri, Lc. lactis, Lb. rhamnosus G5435 (LG5435), Lactobacillus acidophilus 
2401 (LA2401), Lb. acidophilus 388 (LA388), Lactobacillus delbrueckii ssp. bulgaricus 11842 (LB11842), and S. thermophilus 1342 (ST1342)] were 
collected. The PBMC in Roswell Park Memorial Institute (RPMI) medium alone (nonstimulated PBMC) were evaluated as controls for basal 
cytokine production. Purified LPS (1 μg/mL) from Escherichia coli O111:B4 and concanavalin A (5 μg/mL; ConA) from Canavalia A were used 
as positive controls. The concentration of cytokines was subsequently determined using ELISA kits. Results are expressed as the mean cytokine 
response (pg/mL) ± SEM as error bars of each treatment from triplicate wells run as 4 independent experiments.
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Figure 4 (Continued). In vitro production of IL-2 (a), IL-4 (b), IL-10 (c), IL-12 (d), IFN-γ (e), tumor necrosis factor α (TNF-α; f), and 
transforming growth factor β (TGF-β; g). Supernatants of 24-, 48-, 72-, and 96-h cocultures of pooled buffy coat-derived peripheral blood mono-
nuclear cells (PBMC) treated with cell-free supernatants of 17 strains of lactic acid bacteria [Lactobacillus casei 290 (LC290), Bifidobacterium 
breve BB99 (BB99), Bifidobacterium animalis ssp. lactis BB12 (BB12), Bifidobacterium longum 1941 (BL1941), Lactococcus lactis R704 (LCR704), 
Lactobacillus plantarum 276 (LP276), Lactobacillus rhamnosus 5434 (LR5434), Streptococcus thermophilus M5 (STM5), Lactobacillus paracasei 
292 (LP292), Lactobacillus salivarius 5248 (LS5248), Lactobacillus reuteri, Lc. lactis, Lb. rhamnosus G5435 (LG5435), Lactobacillus acidophilus 
2401 (LA2401), Lb. acidophilus 388 (LA388), Lactobacillus delbrueckii ssp. bulgaricus 11842 (LB11842), and S. thermophilus 1342 (ST1342)] were 
collected. The PBMC in Roswell Park Memorial Institute (RPMI) medium alone (nonstimulated PBMC) were evaluated as controls for basal 
cytokine production. Purified LPS (1 μg/mL) from Escherichia coli O111:B4 and concanavalin A (5 μg/mL; ConA) from Canavalia A were used 
as positive controls. The concentration of cytokines was subsequently determined using ELISA kits. Results are expressed as the mean cytokine 
response (pg/mL) ± SEM as error bars of each treatment from triplicate wells run as 4 independent experiments.
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Cytokine Production by PBMC upon Stimulation  
with Cell-Free Supernatants of Probiotic  
and LAB Strains
The effects of cell-free extracts of probiotic and LAB 
strains on cytokine production at different time inter-
vals are shown in Figures 1, 2, and 4a to g. The pro-
duction of Th1-type cytokine IFN-γ and TNF-α were 
induced by PBMC stimulated with cell-free culture 
supernatants in significantly (P < 0.05) low quanti-
ties compared with PBMC stimulated with live strains 
(data not shown) and cell-surface components of tested 
strains. Moreover, cell-free culture supernatants of all 
tested bacterial strains induced PBMC for significant 
production (P < 0.05) of the Th2-type cytokine IL-10 
compared with unstimulated cells, but less than LPS-
stimulated cells. The pattern of IL-10 production for 
cell-surface components of probiotic and LAB strains 
found was similar to PBMC stimulated with same live 
strains (data not shown). Cell-free culture superna-
tants of Lc. lactis, Lb. acidophilus 2401, Lb. rhamno-
sus G5434, S. thermophilus 1342, and Lb. acidophilus 
388 also induced significantly high levels (P < 0.05) 
of IL-2. Compared with unstimulated PBMC, cell-free 
culture supernatants of Lb. delbrueckii ssp. bulgaricus 
stimulated significantly high (P < 0.05) TNF-α pro-
duction at 96 h, followed by Lb. plantarum 276 and 
Lb. rhamnosus 5434. The highest yield of IL-12 was 
obtained at 72 h of stimulation, where cell-free culture 
supernatants of Lc. lactis induced significantly higher 
(P < 0.05) of IL-12 compared with controls, followed 
by Lb. acidophilus 2401, Lb. rhamnosus G5434, B. breve 
99, S. thermophilus 1342, Lb. casei 290, Lb. plantarum 
276, Lb. salivarius 5248 and Lb. reuteri. Results in the 
current study are in line with a previous report (Me-
dina et al., 2007), in which the metabolites secreted 
into the external medium were not much involved in 
proinflammatory responses but share antiinflammatory 
responses of LAB and probiotic strains.
Induction of CD25 Expression in PBMC  
by Cell-Surface Components  
of Probiotic and LAB Strains
Regulatory T cell induction based on expression 
of CD25 activation marker in PBMC from a healthy 
donor was assessed following 96 h of treatment with 
crude cell-surface components of 17 bacteria, controls, 
and LPS-treated cells. The percentages of CD4+CD25+ 
lymphocyte cells and representative FACS plots for 
CD25 expression obtained for cell-surface structures 
and LPS- treated and untreated PMBC are shown 
in Figures 5a and b. Data suggested that the number 
of CD4+ T cells expressing CD25 cells increased sig-
nificantly (P < 0.05) in stimulated PMBC compared 
with control. Among the cell-surface protein fraction 
of tested bacterial cultures, CD25 expression was 
found significantly (P < 0.01) high for the samples of 
S. thermophilus 1342, followed by Lb. casei 290, Lb. 
paracasei 292, S. thermophilus M5, Lb. delbrueckii ssp. 
bulgaricus 11842, B. lactis BB12, Lb. rhamnosus G5434, 
Lb. rhamnosus 5434, and Lc. lactis as compared with 
LPS-stimulated PBMC.
Induction of CD25 Expression in PBMC by Cell-Free 
Supernatants of Probiotic and LAB Strains
The CD25 expression in PBMC stimulated with cell-
free extracts of each probiotic and LAB strains of the 
17 bacteria, RPMI 1640 (control), MRS, and LPS are 
shown in Figures 6a and b. Results indicate that none 
of the cell-free extracts induced increased expression of 
CD3+CD4+CD25+ T lymphocytes in PBMC more than 
LPS-induced cells. Cell-free extracts of 3 strains of Bi-
fidobacterium (BL1941, BB12, and BB99) and 2 strains 
of Lactobacillus (Lb. salivarius 5248 and Lb. paracasei 
292) showed similar CD25 expression to that of LPS 
induction, with approximately 1.6-fold more than un-
stimulated PBMC. Moreover, compared with untreated 
PBMC, the percentages of CD3+CD4+CD25+ T cells 
were found substantially more in PBMC induced with 
cell-free supernatants of Lb. casei 290 followed by Lb. 
acidophilus 388, Lb. acidophilus 2401, Lc. lactis R704, 
and Lb. rhamnosus 5434.
DISCUSSION
The current study demonstrated differential cytokine 
profile for cell-surface components and cell-free culture 
supernatants of 17 probiotic and LAB strains consisting 
of Lactobacillus, Bifidobacterium, Streptocococcus, and 
Lactococcus species after coculturing with buffy coat-
derived PBMC from healthy donors. The cell-surface 
components obtained from sonication of probiotic and 
LAB strains led to increased production of pro- and 
antiinflammatory cytokines by PBMC, suggesting the 
importance of bacterial cell-surface structures in im-
muno-stimulatory activities. The initial findings from 
part of an ongoing study (data not shown) and previous 
research done in our laboratory, suggest that strain dif-
ferences do exist in cytokine production when PBMC 
are stimulated with live strains (Donkor et al., 2012). 
Similarly, in the present study, magnitude of responses 
for each cytokine released from PBMC varied depend-
ing on the type of stimulant, such as metabolites and 
cell-surface components of individual strain that may 
be attributed to strain specificity. These findings add 
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Figure 5. Expression of activation marker CD25 by lymphocytes in response to cell-surface components of 17 lactic acid bacterial strains. 
Peripheral blood mononuclear cells (PBMC) were cultured with cell-surface components of 17 lactic acid bacterial strains [Lactobacillus casei 
290 (LC290), Bifidobacterium breve BB99 (BB99), Bifidobacterium animalis ssp. lactis BB12 (BB12), Bifidobacterium longum 1941 (BL1941), 
Lactococcus lactis R704 (LCR704), Lactobacillus plantarum 276 (LP276), Lactobacillus rhamnosus 5434 (LR5434), Streptococcus thermophilus 
M5 (STM5), Lactobacillus paracasei 292 (LP292), Lactobacillus salivarius 5248 (LS5248), Lactobacillus reuteri, Lc. lactis, Lb. rhamnosus G5435 
(LG5435), Lactobacillus acidophilus 2401 (LA2401), Lb. acidophilus 388 (LA388), Lactobacillus delbrueckii ssp. bulgaricus 11842 (LB11842), and 
S. thermophilus 1342 (ST1342)] for 96 h and evaluated for the expression of CD25 on T lymphocytes. Data were acquired using fluorescence-
activated cell sorter (FACS) Calibur and analyzed by flowlogic software. (a) The percentages of CD3+CD4+CD25+ cells were assessed after extra-
cellular staining of 96 h of coculture. Plots were gated on CD3. Significant differences among samples were established using the least significant 
difference test. Means in the same graphic representation with different letters (a–i) are significantly different (P < 0.05). (b) Representative 
FACS plots for cultures described in (a); one representative experiment is shown of 3 different donors and from 17 cell-free culture samples of 
live strains used in these experiments.
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Figure 6. Expression of activation marker CD25 by lymphocytes in response to cell-free culture supernatants of 17 lactic acid bacte-
rial strains. Peripheral blood mononuclear cells (PBMC) were cultured with cell-free culture supernatants of 17 lactic acid bacterial strains 
[Lactobacillus casei 290 (LC290), Bifidobacterium breve BB99 (BB99), Bifidobacterium animalis ssp. lactis BB12 (BB12), Bifidobacterium longum 
1941 (BL1941), Lactococcus lactis R704 (LCR704), Lactobacillus plantarum 276 (LP276), Lactobacillus rhamnosus 5434 (LR5434), Streptococcus 
thermophilus M5 (STM5), Lactobacillus paracasei 292 (LP292), Lactobacillus salivarius 5248 (LS5248), Lactobacillus reuteri, Lc. lactis, Lb. rham-
nosus G5435 (LG5435), Lactobacillus acidophilus 2401 (LA2401), Lb. acidophilus 388 (LA388), Lactobacillus delbrueckii ssp. bulgaricus 11842 
(LB11842), and S. thermophilus 1342 (ST1342)] for 96 h and evaluated for the expression of CD25 on T lymphocytes. de Man, Rogosa, and 
Sharpe (MRS) media without any inoculation was run as another negative control. Data were acquired using fluorescence-activated cell sorter 
(FACS) Calibur and analyzed by flowlogic software. (a) The percentages of CD3+CD4+CD25+ cells were assessed after extracellular staining of 
96 h of coculture. Plots were gated on CD3. Significant differences among samples were established using the least significant difference test. 
Means in the same graphic representation with different letters (a–i) are significantly different (P < 0.05). (b) Representative FACS plots for 
cultures described in (a); one representative experiment is shown of 3 different donors and from 17 cell-free culture samples of live strains used 
in these experiments. 
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important information for the screening of probiotic and 
LAB strains for future clinical trials and their use as a 
food supplement for the treatment of immune-mediated 
diseases such as allergies and autoimmune disorders.
The stimulation of PBMC with cell-surface struc-
tures demonstrated a similar pattern to that obtained 
from stimulation of PBMC with live strains (data not 
shown). Our findings show that cell-surface components 
of probiotic bacteria are critical and play a major role 
in stimulating immune responses. Some of the varia-
tions in cytokine responses from live versus cell-surface 
structures of these bacteria may be due to differences 
in the efficiency of sonication method among strains. 
Of note, the variations from live versus cell surface 
fractions are unlikely due to donor variations, because 
the stimulation experiments were performed in paral-
lel using PBMC from same donors and supernatants 
were collected simultaneously and stored at −20°C for 
cytokine analysis. The differences for some cytokine 
responses, establishes that compounds other than cell 
metabolites or associated with cell surfaces could have 
been involved the immuno-stimulatory activities of 
these bacteria. These components might work in com-
bination with other bacterial fragments, metabolites, or 
structural motifs to interact with the receptors on mono-
cytes to induce optimal cytokine release (Amrouche 
et al., 2006). We found that TNF-α production was 
greater when PBMC were stimulated with live popula-
tion than cell-surface structures or culture-free extracts 
of probiotic and LAB strains. It has been stated that 
whole bacterial cells are a more effective stimulus for 
TNF-α induction than purified cell-surface fractions or 
peptidoglycans (Timmerman et al., 1993). This shows 
that different mechanisms of stimulation could work for 
some cytokine production, such as TNF-α or IFN-γ, 
which might require direct cell-cell contact. Similarly, 
Lb. rhamnosus GG has been shown to exert specific an-
tiapoptotic effects, for which direct contact was needed, 
through the inhibition of TNF-α-stimulated activation 
of the proapoptotic mitogen-activated protein kinase 
p38 (Yan et al., 2007). Studies have also shown that 
some host pathways are modulated by direct contact 
(Resta-Lenert and Barrett, 2003, 2006; Yan et al., 
2007), but factors involved in eliciting the response by 
cell-cell contact are yet to be identified.
Consistent with a previous report (Medina et al., 
2007), our results demonstrate that TNF-α production 
was induced in comparatively negligible amounts by 
cell-surface structures of LAB strains. The production 
of the TNF-α cytokine in response to bacteria has been 
related to the tertiary structures of cell-surface proteins 
and peptidoglycan, which could have been disrupted 
during extraction procedure by sonication. Prolonged 
sonication has been reported to affect induction of 
TNF-α release by monocytes either by modification in 
tertiary structure or size reduction of macromolecules 
or both (Timmerman et al., 1993).
Secretion of some cytokines affects the induction of 
others. For instance, IL-12 is a multifunctional cyto-
kine, described as a maturation factor for cytotoxic 
T lymphocytes and a stimulatory factor for NK cells, 
resulting in induction of IFN-γ production (Bermúdez-
Humarán et al., 2003). Interferon-γ is known to be a 
major macrophage-activating lymphokine, such as 
IL-4, IL-5, and IL-10 (Meydani and Ha, 2000; Am-
rouche et al., 2006). In addition, TNF-α expression in 
macrophages is regulated by IFN-γ through interferon 
regulatory factor 1 and 8 (Vila-del Sol et al., 2008). 
Therefore, in the present study, less IFN-γ released by 
monocytes for both samples of cell metabolites and 
cell-surface structures could be attributed to decreased 
levels of TNF-α.
The cellular components of probiotic organisms have 
been demonstrated to stimulate monocyte or macro-
phage in similar fashion as do other gram-positive bac-
teria or their cell components (Dogi et al., 2010). Some 
of these fractions have been used in studies to demon-
strate relative efficiencies of individual purified compo-
nents, such as LPS (from E. coli), peptidoglycan (from 
Staphylococcus aureus), and lipoteichoic acids (from 
Staphylococcus aureus and Enterococcus faecalis) in the 
stimulation of PBMC for the production of cytokines, 
including TNF-α, IL-6, and IL-10. Lipopolysaccharide 
was graded as 100 to 1,000 times more efficient than 
peptidoglycan, and peptidoglycan was ranked 10 to 100 
times more effective than lipoteichoic acids. Moreover, 
LPS-induced production of proinflammatory cytokines 
TNF-α, IL-6, and IL-10 (Erickson and Hubbard, 2000; 
Hessle et al., 2005). In line with observations reported 
in these studies, our data established that LPS is a 
strong inducer of TNF-α, IFN-γ, and IL-10, but a poor 
inducer of TGF-β and IL-12. Interestingly, a majority 
of cell-surface components of probiotic and LAB proved 
to be more efficient than LPS in inducing the produc-
tion of IL-2, IL-4, IL-12, and TGF-β, but the responses 
for IL-10 and TNF-α were more or less similar for both.
Chen et al. (1999) reported that gram-positive cell 
walls of the normal intestinal bacteria induce human 
PBMC to produce TNF-α and IL-10, but not IL-4 or 
IFN-γ. However, in our study, crude cell-surface frac-
tions of probiotic and LAB strains induced substantial 
production of IL-10 and TNF-α and negligible IFN-γ 
(with one exception for LB11842), whereas IL-4 was 
induced by majority of the samples (range of 4–163 
with a median of 34.3 pg/mL at 72 h). The secretion 
of TNF-α and IL-10 from monocyte-macrophage U937 
2556 ASHRAF ET AL.
Journal of Dairy Science Vol. 97 No. 5, 2014
cell line treated with purified lipoteichoic acid from 
probiotic strain Lb. acidophilus A9 has also been re-
ported in a dose-dependent way (Dogi et al., 2010). 
Furthermore, other studies reported induction of IL-10 
and antiinflammatory properties of cell wall and me-
tabolites of probiotic bacteria (Amrouche et al., 2006; 
Hoarau et al., 2006; Medina et al., 2007; Jensen et al., 
2010). In the current study, spent culture media for 
the strains of probiotic and lactic acid substantially in-
duced IL-10 but not TNF-α production. These findings 
suggest that both bacterial metabolites and cell-surface 
structures are involved in antiinflammatory responses 
by probiotic and LAB strains through IL-10 secretion; 
however, proinflammatory immune responses mediated 
through TNF-α secretion are predominantly directed 
by bacterial cell-surface structures.
The cell protein fraction of Lc. lactis induced sig-
nificant (P < 0.05) production of IL-12 and IL-2 in 
our study, in accordance with Bermúdez-Humarán et 
al. (2003), who demonstrated the secretion of IL-12 by 
Lc. lactis. This bacterium has been used successfully 
as live bacterial delivery vector (Bermúdez-Humarán 
et al., 2011). Moreover, it has the ability to modulate 
maturation of dendritic cells and is known to elicit 
innate inflammatory responses (Wells and Mercenier, 
2008; Rottiers et al., 2009). Lactic acid bacteria, in-
cluding Lc. lactis, have established safety profile and 
generally regarded as safe status through a long history 
of use in fermented dairy products. The fact that these 
strains express many antigens, induce different cyto-
kine profiles, and can elicit both systemic and mucosal 
immunity, make probiotic and LAB strains attractive 
candidates for the development of mucosal vaccines.
The induction of CD4+CD25+ Treg cells after stimu-
lation of PBMC with cell-surface fractions and secreted 
metabolites of 17 strains of LAB and probiotic bac-
teria show that the induction of Treg cells appeared 
to be influenced by cellular surface structures and 
metabolites of the probiotic and LAB strains, with 
cell-surface components showing higher induction. The 
CD4+CD25+ Treg cells are involved in maintaining 
self-tolerance by downregulating immune response to 
self and nonself antigens (Sakaguchi et al., 1995). For 
their viability and suppressive function, CD4+CD25+ 
Treg have shown in vitro to require direct contact of 
regulatory cells with target cells and secretion of the 
immuno-regulatory cytokines IL-10, TGF-β, including 
small amounts of IL-2 (von Boehmer, 2005; Fantini et 
al., 2007; Bollyky et al., 2009; Lavasani et al., 2010). 
This was affirmed in our study, as IL-10, TGF-β, and 
IL-2 were released by PBMC treated with probiotic and 
LAB strains. The trend in induction CD25 expression 
by cell-surface fractions corresponds to the expression 
obtained from PBMC stimulated with live strains. It is 
believed from the results that the cell-surface structures 
have a primary inductive role in Treg differentiation.
As elimination or decline of CD4+CD25+ cells is im-
plicated with enhanced immune responses to nonself 
and self antigens (Sakaguchi et al., 1995), an increased 
number of regulatory cells by probiotic induction could 
help in controlling autoimmune diseases. In this respect, 
strains of probiotic and LAB, including S. thermophilus 
1342, Lb. casei 290, Lb paracasei 292, S. thermophi-
lus M5, Lb. delbrueckii ssp. bulgaricus 11842, B. lactis 
BB12, Lb. rhamnosus G5434, Lb. rhamnosus 5434, Lc. 
lactis, Bifidobacterium spp. (BL1941, BB12 and BB99), 
and Lb. salivarius 5248, demonstrating high induction 
of CD25 expression could be potential candidates in 
maintaining self-tolerance and, in turn, help in the 
treatment of autoimmune diseases. Prior to in vivo 
studies in our laboratory, the current paper focused on 
the differences and variations in immune responses of 
probiotic strains and studied in detail the in vitro or 
ex vivo characteristics and behavior of these strains on 
human PBMC. These findings will serve as precursor 
for further studies on animal model to validate their 
specific clinical applications.
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